Macrogenics (MGNX) Net Margin (2012 - 2026)

Macrogenics' (MGNX) quarterly Net Margin came in at 187.28% in Q1 2026, up 13651.0% year-on-year from N/an in Q1 2025, and down 446.55% on a QoQ basis from 34.27% in Q4 2025.

Macrogenics (MGNX) Net Margin (2012 - 2026) Analysis & Trends

Macrogenics (MGNX) has 15 years of Net Margin data on file, last reported at 187.28% in Q1 2026.

  • On a quarterly basis, Net Margin rose 13651.0% year-over-year to 187.28% in Q1 2026; TTM through Mar 2026 was 46.13%, a 1322.0% decrease from a year earlier, with the FY2025 full-year figure at 49.89%, down 524.0% from the prior year.
  • Net Margin for Q1 2026 stood at 187.28%, down from 34.27% in the prior quarter.
  • Over the last five years, Net Margin for MGNX reached as high as 50.86% in Q3 2024 and fell as low as 1100.56% in Q1 2024.
  • Historically, Net Margin has averaged 261.8% across 5 years, with a median of 187.28% in 2026.
  • Across the five-year window, Net Margin jumped 274367 bps in 2022 and plunged 91174 bps in 2024, its largest moves.
  • Year by year, Net Margin stood at 16.39% in 2022, then slumped by 2908 bps to 460.39% in 2023, then jumped by 92 bps to 38.55% in 2024, then advanced by 11 bps to 34.27% in 2025, then plunged by 447 bps to 187.28% in 2026.
  • Per Business Quant data, the three most recent Net Margin figures were 187.28% in Q1 2026, 34.27% in Q4 2025, and 23.09% in Q3 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Net Margin (Qtr)
1 Oculis Holding AG 68,785.72 Bn 68,785.72 Bn - -
2 Nanobiotix 1,895.57 Bn 1,895.51 Bn - -
3 BeOne Medicines 471.35 Bn 466.56 Bn 1.35 Bn 15.02%
4 NuCana 279.75 Bn 279.75 Bn - -
5 Vertex Pharmaceuticals 120.24 Bn 113.00 Bn 2.59 Bn 34.53%
6 Regeneron Pharmaceuticals 67.80 Bn 59.04 Bn 3.31 Bn 20.17%
7 Belite Bio 62.51 Bn 62.51 Bn - -
8 Argenx Se 57.38 Bn 57.38 Bn 1.41 Bn 30.33%
9 Revolution Medicines 37.78 Bn 37.78 Bn - -
10 Macrogenics 254.43 Mn 187.92 Mn - -187.28%

Historic Data

Download Data
DateValue
Mar 31, 2026 -187.28%
Dec 31, 2025 -34.27%
Sep 30, 2025 23.09%
Jun 30, 2025 -162.99%
Mar 31, 2025 -323.79%
Dec 31, 2024 -38.55%
Sep 30, 2024 50.86%
Jun 30, 2024 -515.55%
Mar 31, 2024 -1,100.56%
Dec 31, 2023 -460.39%
Sep 30, 2023 -341.46%
Jun 30, 2023 -358.21%
Mar 31, 2023 -188.82%
Dec 31, 2022 16.39%
Sep 30, 2022 -59.80%
Jun 30, 2022 -160.76%
Mar 31, 2022 -608.43%
Dec 31, 2021 -2,727.28%
Sep 30, 2021 -465.53%
Jun 30, 2021 -306.29%